01093 CSPC PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.27X | Oper Margin | 19.7% |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | 14.9% |
| Total Debt/Equity | 1.6% | Return on Equity | 13.4% |
| Price/Book | 2.60X | Return on Assets | 9.8% |
| (HKD 7.660) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 4,602.87 | 6,473.58 | 6,829.67 | 6,855.70 | 6,123.48 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -28.9 | -5.2 | -0.4 | +12.0 | +47.5 |
| Earnings Per Share (HKD) | 0.392 | 0.545 | 0.573 | 0.574 | 0.512 |
| Earnings Per Share Growth (%) | -28.1 | -4.9 | -0.1 | +12.0 | +47.5 |
| Dividend Per Share (HKD) | 0.260 | 0.280 | 0.210 | 0.180 | 0.128 |
| P/E* (X) | 19.54 | 14.05 | 13.37 | 13.36 | 14.96 |
| Yield (%) | 3.39 | 3.66 | 2.74 | 2.35 | 1.66 |
| Dividend Share (%) | 66.31 | 51.35 | 36.64 | 31.39 | 24.89 |
| Book NAV (HKD) | 2.948 | 3.075 | 2.837 | 2.660 | 2.214 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-14 21:40:20
Latest Result
| (RMBMn) | 2025-09 | 2024-09 | Chg* (%) | 2023-09 |
| Cover Period (mths) | 9 | 9 | NA | 9 |
|---|---|---|---|---|
| Turnover | 19,891 | 22,686 | -12.3 | 23,865 |
| Operating Result | 4,342 | 4,826 | -10.0 | 5,615 |
| Associates | -39.509 | -80.972 | -51.2 | -38.473 |
| Profit Before Taxation | 4,303 | 4,746 | -9.3 | 5,610 |
| Taxation | 766.085 | 942.703 | -18.7 | 964.743 |
| Profit /( Loss) After Taxation | 3,536 | 3,803 | -7.0 | 4,645 |
| Minority Interests | 25.051 | 24.771 | +1.1 | 150.375 |
| Net Profit | 3,511 | 3,778 | -7.1 | 4,495 |
| Earnings Per Share () | 0.3356 | 0.3547 | -5.4 | 0.4058 |
| Announcement Date | 2025-11-20 | 2024-11-15 | NA | 2023-11-30 |
* Annualised
Last Update Time: 2025-12-14 21:40:25
